Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells
T. Ohashi et al., Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells, J VIROLOGY, 73(7), 1999, pp. 6031-6040
Human T-cell leukemia virus type 1 (HTLV-1) has been shown to be the etiolo
gic agent of adult T-cell leukemia (ATL), but the in vivo mechanism by whic
h the virus causes the malignant transformation is largely unknown. In orde
r to investigate the mechanisms of HTLV-1 leukemogenesis, we developed a ra
t model system in which ATL-like disease was reproducibly observed, followi
ng inoculation of various rat HTLV-1-immortalized cell lines. When previous
ly established cell lines, F344-S1 and TARS-1, but not TART-1 or W7TM-1, we
re inoculated, systemic multiple tumor development was observed in adult nu
de (nu/nu) rats. FPM1 cells, newly established from a heterozygous (nu/+) r
at syngeneic to nu/nu rats, caused transient tumors only at the injection s
ite in adult nu/nu rats, but could progressively grow in newborn nu/nu rats
and metastasize in lymph nodes. The derivative cell line (FPM1-V1AX) seria
lly passed through newborn nu/nu rats acquired the potency to grow in adult
nu/nu rats. These results indicated that only some with additional changes
but not all of the in vitro HTLV-1-immortalized cell lines possessed in vi
vo tumorigenicity. Using the syngeneic system, we further showed the inhibi
tion of tumor development by transferring splenic T cells from immunized ra
ts, suggesting the involvement of T cells in the regression of tumors. This
novel and reproducible nude rat model of human ATL would be useful for inv
estigation of leukemogenesis and antitumor immune responses in HTLV-1 infec
tion.